NO950986D0 - Kryssbundne og reduserte kontrastmidler - Google Patents

Kryssbundne og reduserte kontrastmidler

Info

Publication number
NO950986D0
NO950986D0 NO950986A NO950986A NO950986D0 NO 950986 D0 NO950986 D0 NO 950986D0 NO 950986 A NO950986 A NO 950986A NO 950986 A NO950986 A NO 950986A NO 950986 D0 NO950986 D0 NO 950986D0
Authority
NO
Norway
Prior art keywords
contrast agents
gas
proteinaceous
crosslinked
size distribution
Prior art date
Application number
NO950986A
Other languages
English (en)
Norwegian (no)
Other versions
NO950986L (no
Inventor
Jo Klaveness
Paal Rongved
John Henrik Johansen
Per Antonius Foss
Anders Hoegseth
Anne Marie Hvoslef
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929219595A external-priority patent/GB9219595D0/en
Priority claimed from GB929220638A external-priority patent/GB9220638D0/en
Priority claimed from GB929220639A external-priority patent/GB9220639D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO950986L publication Critical patent/NO950986L/no
Publication of NO950986D0 publication Critical patent/NO950986D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO950986A 1992-09-16 1995-03-14 Kryssbundne og reduserte kontrastmidler NO950986D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929219595A GB9219595D0 (en) 1992-09-16 1992-09-16 Improvements in or relating to contrast agents
GB929220638A GB9220638D0 (en) 1992-09-30 1992-09-30 Improvements in or relating to contrast agents
GB929220639A GB9220639D0 (en) 1992-09-30 1992-09-30 Improvements in or relating to contrast agents
PCT/GB1993/001861 WO1994006477A1 (fr) 1992-09-16 1993-09-03 Amelioration concernant les agents de contraste

Publications (2)

Publication Number Publication Date
NO950986L NO950986L (no) 1995-03-14
NO950986D0 true NO950986D0 (no) 1995-03-14

Family

ID=27266368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950986A NO950986D0 (no) 1992-09-16 1995-03-14 Kryssbundne og reduserte kontrastmidler

Country Status (13)

Country Link
US (1) US5718884A (fr)
EP (2) EP0660724B1 (fr)
JP (1) JPH08501776A (fr)
CN (1) CN1048410C (fr)
AT (1) ATE167805T1 (fr)
AU (1) AU689086B2 (fr)
CA (1) CA2144749A1 (fr)
DE (1) DE69319438T2 (fr)
DK (1) DK0660724T3 (fr)
ES (1) ES2117715T3 (fr)
FI (1) FI951210A7 (fr)
NO (1) NO950986D0 (fr)
WO (1) WO1994006477A1 (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US6875420B1 (en) 1991-09-17 2005-04-05 Amersham Health As Method of ultrasound imaging
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
EP1550464A1 (fr) 1993-07-30 2005-07-06 IMCOR Pharmaceutical Co. Composition à microbulles stabilisées pour application mettant en oeuvre des ultrasons
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5540909A (en) 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
AU1354497A (en) * 1995-12-21 1997-07-14 Drexel University Hollow polymer microcapsules and method of producing
EP0935415B1 (fr) 1996-05-01 2006-11-22 Imarx Pharmaceutical Corp. Procedes d'apport d'acides nucleiques dans une cellule in vitro
DE19626530A1 (de) * 1996-07-02 1998-01-15 Byk Gulden Lomberg Chem Fab MR-Kontrastmittelzubereitungen
US6108637A (en) 1996-09-03 2000-08-22 Nielsen Media Research, Inc. Content display monitor
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7131997B2 (en) * 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7462366B2 (en) * 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
CA2418229A1 (fr) * 2002-05-16 2003-11-16 Rohan Dharmakumar Structure a microbulles pour manometrie a resonance magnetique amelioree
EP1511522B1 (fr) * 2002-06-12 2011-08-10 Boston Scientific Limited Agents gonflants
US7842377B2 (en) * 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) * 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) * 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7588825B2 (en) * 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7976823B2 (en) * 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US20050074406A1 (en) * 2003-10-03 2005-04-07 Scimed Life Systems, Inc. Ultrasound coating for enhancing visualization of medical device in ultrasound images
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) * 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US20050238870A1 (en) * 2004-04-22 2005-10-27 Marcia Buiser Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) * 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) * 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) * 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070004973A1 (en) * 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
US8123693B2 (en) 2005-06-20 2012-02-28 Conceptus, Inc. Methods and devices for determining lumen occlusion
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US20070083219A1 (en) * 2005-10-12 2007-04-12 Buiser Marcia S Embolic coil introducer sheath locking mechanisms
US8007509B2 (en) * 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US20070142859A1 (en) * 2005-12-19 2007-06-21 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) * 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US20070142560A1 (en) * 2005-12-21 2007-06-21 Young-Ho Song Block copolymer particles
US7947368B2 (en) * 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) * 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
DE102006023456A1 (de) * 2006-05-18 2007-11-22 Siemens Ag Kontrastmittel für die Röntgen- und Computertomographie-Diagnostik
US20070299461A1 (en) * 2006-06-21 2007-12-27 Boston Scientific Scimed, Inc. Embolic coils and related components, systems, and methods
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US20080145658A1 (en) * 2006-12-15 2008-06-19 Boston Scientific Scimed, Inc. Freeze Thaw Methods For Making Polymer Particles
US8585616B2 (en) * 2009-10-09 2013-11-19 Conceptus, Inc. Methods and apparatus for determining fallopian tube occlusion
KR101853948B1 (ko) * 2013-07-05 2018-05-02 사회복지법인 삼성생명공익재단 X-선 조영제 및 기포 촉진제를 함유하는 조영 조성물 및 그 제조방법
CN104174040A (zh) * 2014-08-13 2014-12-03 中国科学院宁波材料技术与工程研究所 一种造影材料、其制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
US5284646A (en) * 1986-07-03 1994-02-08 Advanced Magnetics Inc. Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
DE4004430A1 (de) * 1990-02-09 1991-08-14 Schering Ag Aus polyaldehyden aufgebaute kontrastmittel
JP3247374B2 (ja) * 1990-10-05 2002-01-15 ブラッコ インターナショナル ベスローテン フェンノートシャップ 超音波エコグラフィーに適切な中空気体封入微小球の安定懸濁物の製造のための方法

Also Published As

Publication number Publication date
FI951210A0 (fi) 1995-03-15
DE69319438D1 (de) 1998-08-06
FI951210L (fi) 1995-05-10
WO1994006477A1 (fr) 1994-03-31
CN1048410C (zh) 2000-01-19
ES2117715T3 (es) 1998-08-16
CA2144749A1 (fr) 1994-03-31
DK0660724T3 (da) 1998-11-02
EP0660724A1 (fr) 1995-07-05
EP0835664A3 (fr) 1998-08-12
FI951210A7 (fi) 1995-05-10
NO950986L (no) 1995-03-14
HK1003293A1 (en) 1998-10-23
CN1088114A (zh) 1994-06-22
US5718884A (en) 1998-02-17
JPH08501776A (ja) 1996-02-27
AU4973493A (en) 1994-04-12
AU689086B2 (en) 1998-03-26
EP0835664A2 (fr) 1998-04-15
DE69319438T2 (de) 1998-12-03
ATE167805T1 (de) 1998-07-15
EP0660724B1 (fr) 1998-07-01

Similar Documents

Publication Publication Date Title
NO950986D0 (no) Kryssbundne og reduserte kontrastmidler
US5529766C1 (en) Contrast agents
EP0788348A4 (fr) Recipient contenant une composition polyphasique et s'utilisant dans des applications diagnostiques et therapeutiques
US5558094B1 (en) Methods for using persistent gases as ultrasound contrast media
HUP0000143A2 (hu) Kétfázisú eljárások esszenciális aminosavak felhalmozódásának növelésére magokban
DK0511273T3 (da) Liposomer som kontrastmidler til ultralydsimagografi
CA2273140A1 (fr) Milieux de contraste gazeux pour ultrasons et methode de selection de gaz pouvant etre utilises dans ces milieux
CA2089148A1 (fr) Complexe oxyde comprenant un carboxypolysaccharide hydrosoluble et de l'oxyde de fer magnetique
NO920261L (no) Kontrastmedier
FI935394A0 (fi) Foerbaettringar i betraeffande kontrastmedel
JPS57109797A (en) Preparation of low-molecular weight keratinous substance
PL337287A1 (en) Application of intravenous contrast media in projection mammography
HU9503047D0 (en) 5,6-dihydroxi-indole polymers, process for their preparation and compositions containing them
IT8019327A0 (it) Procedimento d'ottenimento di leghe di manganese a medio tenore in carbonio.
Stewart On the road to scandal.
ES456422A1 (es) Procedimiento para la preparacion de resinas de poliesteres insaturados eventualmente halogenados.
Babij et al. Computerized tomography in kidney neoplasms diagnosis
Ingold 1. 8.3. 3.3 5-Nitroimidazoles: 6.1. 8.3. 3 Heterocyclic nitro radical anions
O'Donnell et al. Hard bargain.
TH12925A (th) สารให้ความเปรียบต่างสำหรับการสร้างภาพด้วยอุลตร้าซาวด์
RU92004556A (ru) Контрастное вещество для ультразвуковой диагностики и способ его получения